David Dismuke, Ph.D., is Vice President of Manufacturing at StrideBio. Dr. Dismuke has spent over a decade in adeno-associated virus manufacturing. He was previously Head of Vector Production at Voyager Therapeutics, Inc., and before that served as the Director of the Vector Core at the University of North Carolina at Chapel Hill, where he oversaw the production of cGMP grade viral vectors for a variety of clinical trials. Dr. Dismuke received a Ph.D. from Vanderbilt University in Microbiology and Immunology.
David Dismuke, Ph.D.
VICE PRESIDENT, MANUFACTURING